These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26631392)

  • 1. Impact of Intracoronary Adenosine on Myonecrosis in Patients with Unstable Angina Pectoris Undergoing Percutaneous Coronary Intervention.
    Kizilirmak F; Gunes HM; Demir GG; Gokdeniz T; Guler E; Cakal B; Omaygenç MO; Yılmaz F; Savur U; Barutcu I
    Cardiovasc Drugs Ther; 2015 Dec; 29(6):519-526. PubMed ID: 26631392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial).
    De Luca G; Iorio S; Venegoni L; Marino P
    Am J Cardiol; 2012 Jan; 109(2):202-7. PubMed ID: 22000773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a randomized controlled trial.
    Kim SJ; Kim W; Woo JS; Ha SJ; Kang WY; Hwang SH; Kang DG; Lee SU; Cho SK; Im JS; Kim W
    Int J Cardiol; 2012 Jun; 158(1):88-92. PubMed ID: 21256606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary adenosine to prevent myonecrosis in patients with stable angina undergoing percutaneous interventions: a double-blinded randomized controlled trial.
    Sanati HR; Ghanavati R; Zahedmehr A; Shakerian F; Bakhshandeh H; Firouzi A; Kiani R
    J Tehran Heart Cent; 2013 Jan; 8(1):28-34. PubMed ID: 23646045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
    Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
    J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study.
    Lee CH; Low A; Tai BC; Co M; Chan MY; Lim J; Lim YT; Tan HC
    Eur Heart J; 2007 Jan; 28(1):19-25. PubMed ID: 17132650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective effects of intracoronary adenosine in diabetic patients undergoing elective percutaneous coronary intervention.
    Shehata M
    Minerva Cardioangiol; 2014 Dec; 62(6):461-71. PubMed ID: 24699551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of short-term high-dose atorvastatin on systemic inflammatory response and myocardial ischemic injury in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
    Sun F; Yin Z; Shi Q; Zhao B; Wang S
    Chin Med J (Engl); 2014; 127(21):3732-7. PubMed ID: 25382328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome.
    Chang SM; Yazbek N; Lakkis NM
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):193-7. PubMed ID: 15170709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
    Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
    JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
    Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
    Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients at low risk for periprocedural myocardial infarction can be identified by assessment immediately following percutaneous coronary intervention.
    Mahmud E; Shaw KD; Penny WF
    J Invasive Cardiol; 2003 Jun; 15(6):343-7. PubMed ID: 12777674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
    Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
    Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Danhong Injection () on Peri-Procedural Myocardial Injury and Microcirculatory Resistance in Patients with Unstable Angina Undergoing Elective Percutaneous Coronary Intervention: A Pilot Randomized Study.
    Xing WL; Wu YJ; Liu HX; Liu QR; Zhou Q; Li AY; Zhang ZH; Li X
    Chin J Integr Med; 2021 Nov; 27(11):846-853. PubMed ID: 34263442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troponin I elevation and cardiac events after percutaneous coronary intervention.
    Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
    Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of index of microcirculatory resistance for early prediction of periprocedural myocardial microcirculatory injury after percutaneous coronary intervention in patients with coronary heart disease].
    You W; Yang ZJ; Ye F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):894-900. PubMed ID: 31744279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.